Literature DB >> 11877573

Increased QTc dispersion and mortality in uremic patients with acute myocardial infarction.

Chia-Liang Wang1, Wen-Lieng Lee, Ming-Ju Wu, Chi-Hung Cheng, Cheng-Hsu Chen, Kuo-Hsiung Shu.   

Abstract

QT dispersion (the difference between maximum and minimum QT across the 12-lead electrocardiogram [ECG]), which reflects regional variations in ventricular repolarization, is a predictor of arrhythmia and cardiovascular mortality. The present study was undertaken to assess the difference in QT dispersion between uremic and nonuremic patients with acute myocardial infarction (AMI) and its relationship to post-AMI clinical outcome. Twelve-lead ECG recordings were obtained the first and third days after the onset of AMI in 21 uremic and 21 nonuremic patients. QT intervals were measured on 12-lead ECGs and corrected by heart rate (QTc). Our findings show that uremic patients with AMI had greater QTc dispersion (84 +/- 35 versus 55 +/- 15 milliseconds; P < 0.001), a greater 1-year mortality rate (48% versus 18%; P = 0.003), and underwent fewer reperfusion therapies (5 of 21 versus 17 of 21 patients; P = 0.002) compared with nonuremic patients with AMI. Patients with AMI who died had greater QTc dispersion than those who survived (102 +/- 40 versus 67 +/- 40 milliseconds; P = 0.015). An optimal QTc dispersion cutoff value of 60 milliseconds had a sensitivity of 100% and specificity of 55% in predicting 1-year mortality in uremic patients with AMI. Uremic patients with AMI administered thrombolytic therapies (n = 5) had reduced 1-year mortality rates (0% versus 63%; P = 0.003) and shortened QTc dispersion from days 1 to 3 (changes in QTc dispersion between days 1 and 3, 29% +/- 9% decrease versus 13% +/- 5% increase; P = 0.001) compared with those without therapies (n = 16). Our findings suggest that greater QT dispersion is associated with greater total mortality, and thrombolytic therapies could reduce QTc dispersion and mortality in uremic patients with AMI. It is prudent to refine our current management regimen for uremic patients with AMI to improve the poor clinical outcome. Copyright 2002 by the National Kidney Foundation, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11877573     DOI: 10.1053/ajkd.2002.31418

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  4 in total

1.  QT dispersion predicts mortality and correlates with both coronary artery calcification and atherosclerosis in hemodialysis patients.

Authors:  Murat Guney; Abdullah Ozkok; Yasar Caliskan; Hamdi Pusuroglu; Halil Yazici; Savas Tepe; Huseyin Oflaz; Alaattin Yildiz
Journal:  Int Urol Nephrol       Date:  2013-09-14       Impact factor: 2.370

2.  The pattern and prognostic features of QT intervals and dispersion in patients with acute ischemic stroke.

Authors:  Oluranti B Familoni; Olatunde Odusan; S Abayomi Ogun
Journal:  J Natl Med Assoc       Date:  2006-11       Impact factor: 1.798

3.  Association of QT dispersion with mortality and arrhythmic events-A meta-analysis of observational studies.

Authors:  George Bazoukis; Cynthia Yeung; Ryan Wui Hang Ho; Dimitrios Varrias; Stamatis Papadatos; Sharen Lee; Ka Ho Christien Li; Antigoni Sakellaropoulou; Athanasios Saplaouras; Panagiotis Kitsoulis; Konstantinos Vlachos; Konstantinos Lampropoulos; Costas Thomopoulos; Konstantinos P Letsas; Tong Liu; Gary Tse
Journal:  J Arrhythm       Date:  2019-11-11

4.  A simple modification of dialysate potassium: its impact on plasma potassium concentrations and the electrocardiogram.

Authors:  Pierre Delanaye; François Krzesinski; Bernard E Dubois; Alexandre Delcour; Sébastien Robinet; Caroline Piette; Jean-Marie Krzesinski; Patrizio Lancellotti
Journal:  Clin Kidney J       Date:  2019-11-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.